elliptinium has been researched along with Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, G; Clavel, M; Dalesio, O; Giaccone, G; Gracia, M; Kirkpatrick, A; McVie, G; Planting, AS; Smyth, J | 1 |
1 other study(ies) available for elliptinium and Carcinoma
| Article | Year |
|---|---|
Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative Group.
Topics: Adenocarcinoma; Aged; Alkaloids; Antineoplastic Agents; Carcinoma; Drug Evaluation; Ellipticines; Female; Humans; Intercalating Agents; Lung Neoplasms; Male; Middle Aged | 1989 |